✦ LIBER ✦

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience

✍ Scribed by Kazuhiko Nakano; Shigeyuki Ohta; Kenji Komatsu; Taro Kubo; Akinori Nukui; Kazumi Suzuki; Shinsuke Kurokawa; Minoru Kobayashi; Tatsuo Morita

Book ID: 115017411
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 198 KB
Volume: 12
Category: Article
ISSN: 1471-2490
DOI: 10.1186/1471-2490-12-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

570Docetaxel, estramustine and prednison

570Docetaxel, estramustine and prednisone for the treatment of hormone refractory prostate cancer: A single center experience

✍ A. Boehmer; S. Feyerabend; M. Kuczyk; A. Merseburger; D. Schilling; A. Stenzl; A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Combination chemotherapy with weekly pac

Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer

✍ Tomihiko Yasufuku; Katsumi Shigemura; Osamu Matsumoto; Soichi Arakawa; Masato Fu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 168 KB

Prognostic and Predictive Factors in Pat

Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience

✍ Aristotle Bamias; George Bozas; Nikolaos Antoniou; Iraklis Poulias; Harilaos Kat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 455 KB

Docetaxel, with or without estramustine

Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial

✍ Orazio Caffo; Teodoro Sava; Evi Comploj; Annamaria Fariello; Fable Zustovich; Ro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Editorial Comment on: Prognostic and Pre

Editorial Comment on: Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience

✍ Sergio Bracarda 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Editorial Comment on: Prognostic and Pre

Editorial Comment on: Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience

✍ Giuseppe Di Lorenzo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB